This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Talia Hahn - Innovator in Immunology
Introduction
Talia Hahn is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of immunology, particularly through her innovative research and development of monoclonal antibodies.
Latest Patents
Talia Hahn holds a patent for a murine monoclonal antibody that binds to TNF.alpha. This cytotoxic protein is expressed by human peripheral blood mononuclear cells and is isolated in an essentially homogenous form. The protein can be utilized to elicit the production of polyclonal or monoclonal anti-cytotoxin antibodies. Furthermore, hybridomas that secrete these anti-cytotoxin antibodies are identified through a solid phase bioassay. The antibodies developed from this research are useful in the immunopurification of cytotoxins. The purified cytotoxic proteins have potential applications in treating virus-infected or tumor target cells, either alone or in combination with interferon or a metabolic blocker.
Career Highlights
Talia Hahn has established herself as a key figure in her field, contributing to advancements in therapeutic approaches for various diseases. Her work has garnered attention for its potential impact on cancer treatment and viral infections.
Collaborations
Talia has collaborated with notable colleagues, including David Wallach and Zelig Eshhar, enhancing the scope and depth of her research.
Conclusion
Talia Hahn's innovative work in the development of monoclonal antibodies represents a significant advancement in immunology. Her contributions continue to influence the field and hold promise for future therapeutic applications.